06 Aug Imbed Biosciences is cleared to sell its silver-enhanced dressing to treat wounds
Imbed Biosciences, a Fitchburg startup whose technology, with tiny silver particles, is used to heal wounds, can start selling its product for use on humans.
The U.S. Food and Drug Administration has cleared Imbed’s Microlyte Ag for prescription and over-the-counter use.
“We are very excited about it,” said Ankit Agarwal, co-founder and CEO, in an interview.
The technology is based on research Agarwal got involved with as a post-doctoral research scientist at the UW-Madison in 2008.
Sorry, the comment form is closed at this time.